Continuous treatment with tafamidis is associated with significant improvements in five-year survival among patients with transthyretin amyloid cardiomyopathy (ATTR-CM), according to new findings published in Circulation: Heart…

Treatment with metoprolol may benefit patients with obstructive hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American College of Cardiology.…

After reviewing decades of data from nearly 100,000 patients, a team of researchers believes they have identified the optimal pharmacological …

Patients with HIV may face an elevated risk of developing heart failure (HF), according to new data published in Mayo Clinic Proceedings.

…

Renal failure of any form is associated with an elevated risk of developing heart failure (HF) among AMI survivors, according to new data published in The American Journal of Cardiology.…

A condensed version of the Kansas City Cardiomyopathy Questionnaire (KCCQ) can help clinicians predict the short- and long-term risk of adverse cardiovascular outcomes among patients with acute heart failure (…

Patients with cardiac amyloidosis presenting with heart failure and new-onset atrial fibrillation (AFib) may benefit from direct oral anticoagulants (DOACs) more than vitamin K antagonists (VKAs), according to new data published in…

Sodium-glucose co-transporter-2 (SGLT2) inhibitors may be associated with a significant reduction in cardiovascular death or hospitalization for heart failure (HHF) among…

Cardiac rehabilitation (CR) is a routine treatment for patients with heart failure (HF), but what is its long-term impact on patient outcomes? A group of researchers asked that very question, sharing its…

Hospitalized COVID-19 patients with a history of heart failure may face a greater risk of in-hospital mortality, according to a new analysis in European Heart Journal. However, the same trend doesn’t appear to be true for any…

Aspirin use is associated with a heightened risk of heart failure (HF) among patients who may already face an elevated HF risk, according to new data published in ESC Heart Failure.

The…

Twelve percent of patients hospitalized for COVID-19 develop shock, according to new data from a research letter published in Circulation: Heart Failure. While cardiogenic shock (CS) makes up a small…

Symptoms of depression are associated with an elevated risk of heart failure with preserved ejection fraction (HFpEF), according to new data published in the Journal of the…

Empagliflozin is associated with a consistent reduction in the risk of adverse outcomes among patients with heart failure with preserved ejection fraction (HFpEF…

Stem cell therapy can help heart failure (HF) patients decrease their risk of a non-fatal myocardial infarction (MI) or stroke, according to new research presented at the American Heart Association’s Scientific Sessions…

Researchers have developed a new tool for identifying transcatheter edge-to-edge repair (TEER) patients who may face a heightened risk of being readmitted to the hospital for heart failure (HF), sharing their findings in Current…

Some immune checkpoint inhibitors (ICIs) may cause serious cardiotoxicities, including myocarditis, according to new data published in Circulation.…

Sacubitril/valsartan does not appear to be a better treatment option for advanced heart failure (HF) than valsartan on its own, according to a new study published in JAMA Cardiology.…

Managing the care of obese heart failure (HF) patients with pulmonary artery (PA) pressure monitoring can lead to reduced PA pressures, fewer HF hospitalizations…

Patients who have diabetes with cardiomyopathy (DbCM) face an elevated risk of developing heart failure (HF),…

The COVID-19 pandemic showed that telehealth can safely and confidently be used by a large health system to treat heart failure (HF) patients, according to new data published in JACC: Heart Failure.

…